An overwhelming majority of evidence has explored an unfavorable prognostic value of PKM2 over-expression in a wide spectrum of cancers [8, 11–13], however, due to variance in tumor type, study design and sample size, several studies failed to draw similar conclusions. Here, PKM is linked to cancer.